Unity Biotechnology Names Federico Grossi Chief Medical …
Jan 6, 2025 · Federico Grossi said he is looking forward to advance UBX1325, and advance pipeline to provide new and differentiated treatment options for patients with progressive retinal diseases.
UNITY Biotechnology Announces Appointment of Federico Grossi…
SAN FRANCISCO, Jan. 06, 2025 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (“UNITY”) [NASDAQ: UBX], a biotechnology company developing therapeutics to slow, halt or reverse diseases of aging, today...
UNITY Biotechnology Announces Appointment of Federico Grossi…
Grossi oversaw the clinical strategy and development programs in ophthalmology, hematology, neurology and nephrology, leading to the approval and commercial launch of EMPAVELI (paroxysmal nocturnal hemoglobinuria) and SYFOVRE (geographic atrophy).
UNITY Biotechnology Appoints Federico Grossi, M.D., Ph.D., as
Jan 6, 2025 · UNITY Biotechnology has appointed Federico Grossi, M.D., Ph.D., as its new chief medical officer to enhance its leadership team. Dr. Grossi, who has over 20 years of experience in biotech ...
UNITY Biotechnology Announces Appointment of Federico Grossi…
SAN FRANCISCO, Jan. 06, 2025 (GLOBE NEWSWIRE) — UNITY Biotechnology, Inc. (“UNITY”) [NASDAQ: UBX], a biotechnology company developing therapeutics to slow, halt or reverse diseases of aging, today strengthened the executive leadership team with the appointment of Federico Grossi, M.D., Ph.D., as chief medical officer.
UNITY Biotechnology Welcomes Dr. Grossi as New CMO to Lead …
Jan 6, 2025 · UNITY Biotechnology, a pioneering firm in the biotechnology sector devoted to combating the effects of aging, has made a significant enhancement to its leadership with the recent appointment of Dr. Federico Grossi as Chief Medical Officer.
UNITY Biotechnology Announces Appointment of Federico Grossi …
SAN FRANCISCO, Jan. 06, 2025 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (“UNITY”) [NASDAQ: UBX], a biotechnology company developing therapeutics to slow, halt or reverse diseases of aging, today...
UNITY Biotechnology Appoints Federico Grossi as Chief Medical …
Jan 6, 2025 · UNITY Biotechnology, Inc. appointed Federico Grossi, M.D., Ph.D., as chief medical officer. Dr. Grossi brings a wealth of experience in clinical development and regulatory strategy in ophthalmology...
Unity Biotechnology Names Federico Grossi Chief Medical …
Jan 6, 2025 · Federico Grossi said he is looking forward to advance UBX1325, and advance pipeline to provide new and differentiated treatment options for patients with progressive retinal diseases. Grossi has 20 years of experience, with rich expertise in ophthalmology.
Unity Biotechnology gets new chief medical officer
Unity Biotechnology (NASDAQ:UBX) appointed Federico Grossi, M.D., Ph.D., as chief medical officer. He has led the development of SYFOVRE for geographic atrophy as chief medical officer at...
- Some results have been removed